Table 4.
Some examples of peptides that can be added on EV surface to target specific organs/cells
| Targeted cells/organs | Peptide | Reference |
|---|---|---|
| Glioma | RGE | Jia et al.104 |
| CNS | RVG | Alvarez-Erviti et al.106 |
| Intracranial glioblastoma | T7 | Kim et al.107 |
| Brain | ApoB | Choi et al.108 |
| Glioblastoma | ApoA-I mimetic peptide | Ye et al.109 |
| Muscles | CP05 | Gao et al.110 |
| Muscles and heart | T9 | Wiklander et al.46 |
| Muscles and heart | M12 | Nance et al., Gao et al.140,141 |
| Cardiomyocytes | IL-3 | Bellavia et al.115 |
| Cardiomyocytes | cardiomyocyte-specific peptide | Mentkowski et al.114 |
| Heart | CTP | Zahid et al.116 |
| Heart | PCM | Nam et al.117 |
| Heart | ischemic myocardium-targeting peptide | Zhu et al.112 |
| Heart | cardiac homing peptide | Vandergriff et al.113 |
| Cartilage | chondrocyte affinity peptide | Liang et al.51 |
| Pancreas | tetraspanin-8 | Nazarenko et al., Rana et al.118,119 |
| Cancer cells | GE11 | Ohno et al.120 |
| Cancer cells | TfR | Song et al.103 |
| Cancer cells | glycans | Berenguer et al.122 |
| Monocyte-derived DCs | MUC1 | Koning et al.123 |